Growth Metrics

Travere Therapeutics (TVTX) Long-Term Debt Issuances (2022)

Travere Therapeutics' Long-Term Debt Issuances history spans 3 years, with the latest figure at $316.2 million for Q1 2022.

  • For Q1 2022, Long-Term Debt Issuances changed N/A year-over-year to $316.2 million; the TTM value through Dec 2022 reached $316.2 million, changed N/A, while the annual FY2022 figure was $316.2 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $316.2 million in Q1 2022 per TVTX's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $316.2 million in Q1 2022 to a low of $316.2 million in Q1 2022.